Efficacy of Compressive Therapy with an Internal Foam Layer in reducing the volume of Breast Cancer related Lymphedema: randomized clinical trial - TECLINF ThErapy Compression for LYMphedema

Hospital do Câncer III0 个研究点开始时间: 2024年5月27日最近更新: 2024年6月25日

试验速览

暂无简介。

•Women aged 18 years and older; diagnosed with upper limb lymphedema after 6 months of surgical treatment for breast cancer; in the volume reduction phase, with 10 to 20% excess volume; classified as stage II according to the International Society of Lymphology classification, in which there is the presence of interstitial fibrosis; with or without a lock sign and with mild to moderate volume changes

•Women undergoing bilateral lymphadenectomy or with bilateral lymphedema; lymphedema since the preoperative period; presence of phlogistic signs in the edematous limb; with lesions with loss of continuity in the skin of the limb with lymphedema; previous history of allergic reaction to the material used for compression therapy; active locoregional or distant disease; undergoing chemotherapy or radiotherapy; those with functional changes in the upper limbs prior to the diagnosis of breast cancer; those with heart disease and decompensated systemic arterial hypertension; psychiatric, mental, neurological disorders or cognitive deficits that make it impossible for them to answer the questionnaires

发起方

Hospital do Câncer III